| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.359 | 11.222 | 10.972 | 12.672 | 14.699 | 9.824 | 9.177 | 10.718 | 9.805 | 15.617 |
| Total Income - EUR | 9.359 | 11.222 | 10.972 | 12.672 | 14.740 | 10.483 | 9.177 | 10.718 | 9.805 | 15.617 |
| Total Expenses - EUR | 4.788 | 5.202 | 4.980 | 7.532 | 7.240 | 6.944 | 5.777 | 6.659 | 4.979 | 6.902 |
| Gross Profit/Loss - EUR | 4.571 | 6.020 | 5.992 | 5.140 | 7.501 | 3.540 | 3.400 | 4.059 | 4.826 | 8.714 |
| Net Profit/Loss - EUR | 4.291 | 5.683 | 5.663 | 4.760 | 7.058 | 3.250 | 3.295 | 3.811 | 4.054 | 7.334 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Elimed Test S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 774 | 681 | 588 |
| Current Assets | 72 | 75 | 142 | 4.972 | 11.824 | 7.285 | 1.916 | 5.727 | 6.577 | 6.911 |
| Inventories | 0 | 0 | 0 | 191 | 0 | 0 | 0 | 401 | 399 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 203 | 443 | 151 |
| Cash | 72 | 75 | 142 | 4.780 | 11.824 | 7.285 | 1.916 | 5.124 | 5.735 | 6.761 |
| Shareholders Funds | -12.513 | -6.703 | -926 | 3.851 | 10.835 | 6.954 | 1.449 | 946 | 4.996 | 7.059 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.601 | 6.777 | 1.068 | 1.155 | 990 | 331 | 467 | 5.556 | 2.262 | 441 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Elimed Test S.r.l.